Unlock instant, AI-driven research and patent intelligence for your innovation.

Method of use of stabilized plant-derived growth factor in skin care

A growth factor and skin care technology, applied in the field of cosmetic and dermatological compositions, can solve the problems of protein glycosylation and instability

Inactive Publication Date: 2012-12-05
ORF ELEVATORAEKNI HF
View PDF10 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, bacteria are unable to glycosylate proteins, which in several cases is known to make them less stable and more susceptible to degradation by proteases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method of use of stabilized plant-derived growth factor in skin care
  • Method of use of stabilized plant-derived growth factor in skin care
  • Method of use of stabilized plant-derived growth factor in skin care

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0080] Embodiment 1: Preparation of the transgenic plant extract containing recombinant EGF

[0081] Transgenic plant extracts are prepared by grinding harvested transgenic barley seeds containing the growth factor EGF in a mill to obtain a fine powder (flour). Extraction buffer (50 mM potassium phosphate, pH 7.0) was added to the ground barley flour at a volume / weight ratio of extraction buffer to ground flour of 5 / 1. The resulting solution was stirred at 4°C for 60 minutes. Centrifuge at 8300 rpm or above for 15 min in a refrigerated centrifuge (Heraeus Primo R) to separate the solids from the liquid extract by centrifugal force and decant the supernatant into clean vials. Extracts were analyzed for growth factor content by SDS-PAGE and Western blotting using EGF-specific antibodies. In this experiment, the EGF content was about 0.01% of the protein content of the extract. The results are shown in figure 1 middle.

[0082] figure 1 (A) shows a portion of the gel stai...

Embodiment 2

[0083] Example 2: Partially purified transgenes containing the growth factors VEGF and dehydrin Plant extracts

[0084] The VEGF-containing transgenic barley seed extract prepared according to Example 1 was further processed by adding to the extract an IMAC chromatography resin that effectively binds VEGF. The mixture of extract and resin was stirred at +4°C for 60 minutes in 50 mM potassium phosphate, pH 7.0, 0.5 M NaCl, 50 mM imidazole. The IMAC resin was separated from the liquid by centrifugation at 5000 xg for 15 minutes. The liquid phase was decanted off, the resin was resuspended in wash buffer (50 mM potassium phosphate, 0.5 M NaCl, 50 mM imidazole; pH 7.0) and centrifuged, and the liquid phase was decanted from the resin. Washing was repeated three times. Resuspend the resin in elution buffer containing imidazole (50 mM potassium phosphate, 0.5 M NaCl, 500 mM imidazole; pH 7.0) to elute VEGF from the resin and decant the supernatant from the resin after centrifu...

Embodiment 3

[0086] Example 3: Extraction of partially purified transgenic plants containing hordeglobulin and IGF-1 thing

[0087] Transgenic barley seeds were extracted according to Example 1 in extraction buffer II (50 mM potassium phosphate, pH 7.0, 200 mM NaCl). The extract was bound to and eluted from IMAC resin as explained in Example 2, and the eluate was subsequently desalted and buffer changed to 100 mM KPi at pH 6.8. The extract was then further processed by adding the partially purified extract to an ion exchange chromatography resin under conditions effective to bind IGF-1, where the matrix used was SP-Sepharose (GE Healthcare). The corresponding fractions were analyzed by SDS-PAGE and silver staining and western blotting using specific anti-IGF-1 antibodies. The partially purified plant extract has an IGF-1 content of 60%.

[0088] image 3 , a partially purified transgenic plant extract containing barley globulin and IGF-1. A) Silver-stained SDS-PAGE gel. Lane numbe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Cosmetic and dermatologic compositions for skin care, containing a transgenic plant extract containing a growth factor, or a growth factor purified from transgenic plants, or a mixture of growth factors derived from transgenic plants as extracts or in purified form, for use in topical therapeutics, dermatology and cosmetics. Importantly this invention provides stabilised,safer growth factors available for use for cosmetic and topical treatment. Preferred composition comprises a plant-produced growth factor and hyaluronic acid. The skin-care / dermatological compositions with stabilised growth factor do not carry the risk of unwanted breakdown products and the resulting loss of activity of the composition. Furthermore, the composition is without contaminants and transmissible agents that can result from animals or animal or bacterial cell based expression systems.

Description

field of invention [0001] In general, the present invention relates to cosmetic and dermatological compositions comprising stabilized growth factors and cytokines for skin care, dermatological applications, and methods of manufacture of skin care products. In particular, the present invention relates to stabilized heterologous growth factors obtained from transgenic plants and their use in cosmetic and pharmaceutical products. Background of the invention [0002] The skin is the largest organ of the human body and performs various functions such as protection, barrier, temperature control, excretion and respiration. With time and aging, these functions rapidly decline, and the skin undergoes various physiological changes. These changes manifest as a decrease in the thickness of the epidermis, dermis, and subcutaneous tissue, which are the main components of the skin. Changes in lipid composition weaken the moisture barrier function of the lipid layer, resulting in dry skin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K8/64A61K38/18A61Q19/00C12N15/82C07K14/485
CPCA61K38/168A61K38/1866A61K38/1808A61K31/728A61K47/02C07K14/485A61K9/0014C12N15/8257A61K8/735A61K9/06A61K38/2006A61Q19/007A61K8/64A61K38/18A61K47/10A61K38/1841A61K47/00A61K38/00
Inventor 埃纳尔·曼缇拉比约恩·拉鲁斯·奥瓦尔约恩·布拉吉·比亚尔纳松伊夫斯·巴尔默
Owner ORF ELEVATORAEKNI HF
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More